Skip to content
Lab150
  • Home
  • About
    • About LAB150
    • Our Partners
    • Our Team
    • Steering Committee
    • TIAP Members
  • Work With Us
    • Our Process
    • FAQ
    • Submit
  • News
    • Events
  • Contact
  • LinkedIn
  • Twitter
Home
•
2018

Year: 2018

Second Project: Glaucoma Research from UHN
MI Member Institution
glaucoma

Second Project: Glaucoma Research from UHN

Toronto, ON, Oct. 04, 2018 (GLOBE NEWSWIRE) — MaRS Innovation announced today the second project to be developed under their LAB150 partnership with Evotec. The project aims to develop a novel therapeutic approach to treat glaucoma, an irreversible neurodegenerative disease of the optic nerve which…

Read Morearrow_forward
October 4, 2018 by Susanne Staer
First Project Announced!
Evotec AG Mt. Sinai Hospital Projects
dermatitis drug development drug therapy pediatrics

First Project Announced!

Hamburg, Germany, and Toronto, Canada, Feb. 15, 2018 (GLOBE NEWSWIRE) — Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and MaRS Innovation announced today that they have identified the first project to be developed under their LAB150 partnership. After signing a collaboration agreement in…

Read Morearrow_forward
February 16, 2018 by Susanne Staer
Recent Posts
  • Webinar: Let’s Get Clinical – Anticipating Clinical Trials in Your Pre-Clinical Work
  • Webinar February 24, 2021 – Adventures in Drug Hunting: Identify and Advance Your Drug-Like Molecule
  • TIAP & Amgen co-fund transformative projects to support new venture development
  • Webinar: Staying on Target: Is your research program ready for drug discovery?
  • Project 7: Novel Therapeutic Agent for Immuno-Oncology from Sunnybrook Research Institute
  • LinkedIn
  • Twitter
2023 LAB150. All rights reserved. | Privacy Policy